1. RETRACTED ARTICLE: microRNA-133a exerts tumor suppressive role in oral squamous cell carcinoma through the Notch signaling pathway via downregulation of CTBP2
   Wei Liu et al, 2022, Cancer Gene Therapy CrossRef
2. CtBP2 interacts with ZBTB18 to promote malignancy of glioblastoma
   Liang Chen et al, 2020, Life Sciences CrossRef
3. Analysis of mutations in CDC27, CTBP2, HYDIN and KMT5A genes in carotid paragangliomas
   E. N. Lukyanova et al, 2018, Vavilov Journal of Genetics and Breeding CrossRef
4. Omic Approach in Non-smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized Medicine
   Margherita Baldassarri et al, 2018, Cancer Research and Treatment CrossRef
5. The transrepression and transactivation roles of CtBPs in the pathogenesis of different diseases
   Zhi Chen, 2021, Journal of Molecular Medicine CrossRef
6. ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma
   Roberto Ferrarese et al, 2023, Life Science Alliance CrossRef
7. MiR-338 suppresses cell proliferation and invasion by targeting CTBP2 in glioma
   De-Zhi Liu et al, 2017, Cancer Biomarkers CrossRef
8. Down-regulation of C-terminal binding protein 2 (CtBP2) inhibits proliferation, migration, and invasion of human SHSY5Y cells in vitro
   Jiang Nan et al, 2017, Neuroscience Letters CrossRef
9. Low CtBP2 expression is associated with a stem cell-like signature and adverse clinical outcome in childhood B-cell lymphoblastic leukemia
   Sejong Chun et al, 2021, Leukemia CrossRef
10. Interactome of miRNAs and transcriptome of human umbilical cord endothelial cells exposed to short-term simulated microgravity
    Dharanibalan Kasiviswanathan et al, 2020, npj Microgravity CrossRef
11. C-terminal binding protein-2 is a prognostic marker for lung adenocarcinomas
    Binfeng Li et al, 2020, Medicine CrossRef